Junru Chen
Tracked across 1 events · 33 articles · First seen May 25, 2026 · Last active Jun 08, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Dr. Junru Chen from West China Hospital, Sichuan University, is presenting on a Phase Ib/II trial of cadonilimab plus axitinib in renal cell carcinoma.
May 25, 2026 · 33 articles
ERGEN INTELLIGENCE
Track Junru Chen live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard